logo-loader
Proactive Group

Investor Update: Chaarat Gold updates BFS for Tulkubash gold prospect

Top stories from the Proactive Investors UK newsroom:

Oncimmune Holdings PLC's (LON:ONC)  lung cancer diagnostic met its primary endpoint of a reduction in people being diagnosed with late stage lung cancer in a large NHS study in Scotland. The study was conducted with 12,210 patients and is believed to be the largest randomised controlled study using biomarkers for the detection of lung cancer.

Chaarat Gold (LON:CGH) has updated its bankable feasibility study for the Tulkubash gold prospect. Based on average annual production of 94,000 ounces and cash costs of US$678 per ounce, the net present value rises to US$70mln. The estimated cost of building the mine has also dropped to US$110mln.

Horizonte Mineral’s (LON:HZM) boss Jeremy Martin has hailed the production of high purity nickel and cobalt sulphate as part of test work undertaken at their Vermelho project. The results will be rolled into the Pre-feasibility Study on the Project.

High profile fund manager Neil Woodford has been forced to suspend trading in his flagship vehicle due to a wave of redemptions.  Investors have withdrawn about £560m from the Woodford Equity Income fund over the past four weeks.

Shell is to hike the amount its pays out in dividends and buybacks after saying the business would generate more cash than previously thought. Organic free cash flow will now be around US$35bn in 2025 at an oil price of $60 per barrel, which gives the potential to distribute US$125bn or even more to shareholders over the five-year period of 2021-2025 .

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

23 hours, 19 minutes ago

2 min read